The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total debt is C$83.35 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | C$86.24 B | 0.63% |
2023-12-31 | C$85.69 B | 62.17% |
2022-12-31 | C$52.84 B | 24.49% |
2021-12-31 | C$42.45 B | 0.93% |
2020-12-31 | C$42.05 B | 7.69% |
2019-12-31 | C$39.05 B | -15.5% |
2018-12-31 | C$46.21 B | 4.02% |
2017-12-31 | C$44.43 B | -4.43% |
2016-12-31 | C$46.49 B | 6.64% |
2015-12-31 | C$43.59 B | 22.32% |
2014-12-31 | C$35.64 B | 4.22% |
2013-12-31 | C$34.20 B | 29.64% |
2012-12-31 | C$26.38 B | 21.03% |
2011-12-31 | C$21.79 B | 63.19% |
2010-12-31 | C$13.35 B | 19.74% |
2009-12-31 | C$11.15 B | -9.85% |
2008-12-31 | C$12.37 B | 10.97% |
2007-12-31 | C$11.15 B | 6.27% |
2006-12-31 | C$10.49 B | 127.76% |
2005-12-31 | C$4.60 B | -24.94% |
2004-12-31 | C$6.13 B | 53.62% |
2003-12-31 | C$3.99 B | -20.22% |
2002-12-31 | C$5.00 B | 873.62% |
2001-12-31 | C$0.51 B | 6.4% |
2000-12-31 | C$0.48 B | 3.94% |
1999-12-31 | C$0.46 B | -7.96% |
1998-12-31 | C$0.50 B | 36.57% |
1997-12-31 | C$0.37 B | 52.47% |
1996-12-31 | C$0.24 B |